
Tale from the Crypt: Belantamab Mafodotin
OncoPharm
00:00
DREAM7 design: combination versus daratumumab
John Bizarro outlines DREAM7 comparing belantamab plus bortezomib-dex to daratumumab with bortezomib-dex and key dosing differences.
Play episode from 03:11
Transcript


